News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
584,933 Results
Type
Article (47858)
Company Profile (135)
Press Release (536929)
Multimedia
Podcasts (141)
Webinars (21)
Section
Business (156634)
Career Advice (2439)
Deals (29742)
Drug Delivery (141)
Drug Development (69374)
Employer Resources (159)
FDA (16407)
Job Trends (12544)
News (279851)
Policy (30607)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2388)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (136)
Alliances (40032)
ALS (164)
Alzheimer's disease (1731)
Antibody-drug conjugate (ADC) (312)
Approvals (16553)
Artificial intelligence (519)
Autoimmune disease (155)
Automation (34)
Bankruptcy (323)
Best Places to Work (9550)
BIOSECURE Act (23)
Biosimilars (190)
Biotechnology (78)
Bladder cancer (160)
Brain cancer (56)
Breast cancer (610)
Cancer (4625)
Cardiovascular disease (417)
Career advice (2064)
Career pathing (38)
CAR-T (260)
CDC (59)
Celiac Disease (1)
Cell therapy (719)
Cervical cancer (37)
Clinical research (59454)
Collaboration (1532)
Company closure (4)
Compensation (1146)
Complete response letters (72)
COVID-19 (2768)
CRISPR (87)
C-suite (782)
Cystic fibrosis (142)
Data (5810)
Decentralized trials (2)
Denatured (32)
Depression (145)
Diabetes (484)
Diagnostics (6916)
Digital health (38)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (218)
Drug pricing (221)
Drug shortages (33)
Duchenne muscular dystrophy (237)
Earnings (65656)
Editorial (65)
Employer branding (20)
Employer resources (142)
Events (86769)
Executive appointments (907)
FDA (19476)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (21)
Funding (1314)
Gene editing (192)
Generative AI (45)
Gene therapy (606)
GLP-1 (1063)
Government (4248)
Grass and pollen (8)
Guidances (377)
Healthcare (15558)
HIV (57)
Huntington's disease (49)
IgA nephropathy (84)
Immunology and inflammation (284)
Immuno-oncology (56)
Indications (95)
Infectious disease (3036)
Inflammatory bowel disease (181)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (237)
Interviews (454)
IPO (14539)
IRA (57)
Job creations (3299)
Job search strategy (1689)
JPM (66)
Kidney cancer (16)
Labor market (81)
Layoffs (620)
Leadership (39)
Legal (7154)
Liver cancer (92)
Longevity (13)
Lung cancer (611)
Lymphoma (356)
Machine learning (42)
Management (53)
Manufacturing (744)
MASH (165)
Medical device (12175)
Medtech (12221)
Mergers & acquisitions (16211)
Metabolic disorders (1310)
Multiple sclerosis (152)
NASH (22)
Neurodegenerative disease (337)
Neuropsychiatric disorders (97)
Neuroscience (2946)
Neurotech (1)
NextGen: Class of 2026 (5180)
Non-profit (3367)
Now hiring (31)
Obesity (654)
Opinion (279)
Ovarian cancer (151)
Pain (190)
Pancreatic cancer (216)
Parkinson's disease (277)
Partnered (26)
Patents (479)
Patient recruitment (450)
Peanut (55)
People (47205)
Pharmaceutical (34)
Pharmacy benefit managers (32)
Phase 1 (17854)
Phase 2 (25738)
Phase 3 (21014)
Pipeline (4920)
Policy (332)
Postmarket research (2239)
Preclinical (7259)
Press Release (34)
Prostate cancer (239)
Psychedelics (54)
Radiopharmaceuticals (265)
Rare diseases (879)
Real estate (4632)
Recruiting (64)
Regulatory (23675)
Reports (40)
Research institute (2216)
Resumes & cover letters (405)
Rett syndrome (27)
RNA editing (16)
RSV (73)
Schizophrenia (151)
Series A (222)
Series B (177)
Service/supplier (8)
Sickle cell disease (95)
Special edition (25)
Spinal muscular atrophy (143)
Sponsored (46)
Startups (2973)
State (1)
Stomach cancer (20)
Supply chain (106)
Tariffs (101)
The Weekly (108)
Vaccines (1086)
Venture capital (94)
Weight loss (462)
Women's health (78)
Worklife (22)
Date
Today (77)
Last 7 days (534)
Last 30 days (1953)
Last 365 days (28712)
2026 (2788)
2025 (29033)
2024 (32355)
2023 (36205)
2022 (46607)
2021 (50243)
2020 (47356)
2019 (37775)
2018 (28708)
2017 (29174)
2016 (27461)
2015 (30226)
2014 (23690)
2013 (19516)
2012 (20907)
2011 (21400)
2010 (19318)
Location
Africa (731)
Alabama (69)
Alaska (6)
Arizona (252)
Arkansas (10)
Asia (33993)
Australia (5922)
California (10437)
Canada (2630)
China (919)
Colorado (414)
Connecticut (460)
Delaware (303)
Europe (82876)
Florida (1580)
Georgia (327)
Hawaii (4)
Idaho (42)
Illinois (759)
India (56)
Indiana (429)
Iowa (22)
Japan (405)
Kansas (107)
Kentucky (29)
Louisiana (21)
Maine (74)
Maryland (1294)
Massachusetts (7557)
Michigan (275)
Minnesota (594)
Mississippi (5)
Missouri (118)
Montana (17)
Nebraska (27)
Nevada (110)
New Hampshire (71)
New Jersey (2827)
New Mexico (28)
New York (2766)
North Carolina (1418)
North Dakota (9)
Northern California (5159)
Ohio (291)
Oklahoma (18)
Oregon (37)
Pennsylvania (2011)
Puerto Rico (16)
Rhode Island (36)
South America (1087)
South Carolina (64)
South Dakota (1)
Southern California (4061)
Tennessee (151)
Texas (1569)
United States (36914)
Utah (327)
Virginia (245)
Washington D.C. (75)
Washington State (841)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
584,933 Results for "bioporto diagnostics a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioPorto A/S Appoints Chief Financial Officer
February 9, 2026
·
2 min read
Press Releases
Progress Update on BioPorto’s Adult Clinical Study
November 4, 2025
·
5 min read
Press Releases
BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update
February 5, 2026
·
9 min read
Press Releases
ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.
August 28, 2025
·
6 min read
Press Releases
BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes
November 24, 2025
·
4 min read
Press Releases
Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S
November 14, 2025
·
4 min read
Press Releases
BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth
November 19, 2025
·
7 min read
Press Releases
BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented
September 26, 2025
·
3 min read
Press Releases
BioPorto A/S Announces the Appointment of a New CEO as Part of its Succession Planning Strategy
June 11, 2025
·
5 min read
Press Releases
BioPorto A/S to host first quarter 2025 earnings webcast for investors
April 29, 2025
·
1 min read
1 of 58,494
Next
